• The title of the article is clickbait/ragebait. The actual article content is a little different. The gist of it is more so this:

    In place of capping the out-of-pocket cost of just insulin, lawmakers should cap the out-of-pocket cost of all diabetes medications.

    https://archive.is/tvVHP

    Headline writters are often/usually different people than the person who wrote the article leading to infuriating things like this

    • Phoenixz ( phoenixz@lemmy.ca ) 
      link
      fedilink
      English
      arrow-up
      6
      ·
      2 years ago

      Yeah well in this case it basically means that the headline is absolute bullshit. It might as well have said something about puppies.

      News organizations should be held to higher standards here, and be honest ffs

  • Catoblepas ( Catoblepas@lemmy.blahaj.zone ) 
    link
    fedilink
    English
    arrow-up
    31
    ·
    2 years ago

    Hmm, who is this Rose fellow?

    Michael Rose is a senior resident in internal medicine and pediatrics at Johns Hopkins University School of Medicine.

    The only person The Atlantic could find to peddle this shit isn’t even allowed to practice medicine without supervision? lmao

      • Catoblepas ( Catoblepas@lemmy.blahaj.zone ) 
        link
        fedilink
        English
        arrow-up
        5
        ·
        edit-2
        2 years ago

        That’s fair! It’s entirely possible they got rolled by The Atlantic and didn’t know what the editors were going to do to the piece. But like, at the same time maybe question why a national publication would need someone who isn’t able to practice on their own to do an opinion piece about something highly politicized… (them before they agreed to write the piece I mean, if that wasn’t clear)

        • Umbrias ( Umbrias@beehaw.org ) 
          link
          fedilink
          English
          arrow-up
          5
          ·
          2 years ago

          another comment pointed out elsewhere that the titles are rarely made by the writer, so im inclined to believe that the atlantic recieved this piece and wanted to slant it for those who just read the headline, yeah.

  • dogsoahC ( dogsoahC@lemm.ee ) 
    link
    fedilink
    English
    arrow-up
    14
    ·
    edit-2
    2 years ago

    Have you read the article? It’s about how type 2 patients, for whom insulin isn’t the best option and who make up the majority of diabetes patients could end up having to use insulin because it’s cheaper.

    “In place of capping the out-of-pocket cost of just insulin, lawmakers should cap the out-of-pocket cost of all diabetes medications.”

    • Sauerkraut ( Sauerkraut@discuss.tchncs.de ) 
      link
      fedilink
      English
      arrow-up
      5
      ·
      2 years ago

      I apologize if this sounds pedantic, but what if the writer was forced to write it to keep his job along with his family’s access to food, shelter, and healthcare? So rather than punch down, I say punch up. I say fuck the owners who ultimately signed off on the article and potentially demanded it in the first place. (The Atlantic is owned by Emerson Collective which is owned by billionaire Laurene Jobs. )

  • MystikIncarnate ( MystikIncarnate@lemmy.ca ) 
    link
    fedilink
    English
    arrow-up
    5
    ·
    2 years ago

    Pardon me, but, Mr Rose, can you please tell me… What fucking better treatments?

    My brother is T1D and he’s been like that since his teens. Literally the only way for him to continue to live, at all, is to take insulin.

    It’s times like this that make me thankful I don’t live in the USA.

    But seriously, if anyone knows of a “better” treatment for type 1 diabetes, I’m all ears. I’ve been looking for something for my brother for years, and I’ve come up with jack shit.

      • MystikIncarnate ( MystikIncarnate@lemmy.ca ) 
        link
        fedilink
        English
        arrow-up
        1
        ·
        2 years ago

        The most significant insulin development in recent years is glucose reactive insulin.

        I would argue that any development short of GRI is not significantly different than any other insulin treatment. You have to take insulin and either regulate how much insulin you take for how much sugar you consume, or regulate how much sugar you consume too match how much insulin you’re taking.

        The intervals/amounts differ, even methods of administration differ, but they are not drastically different.

        GRIs actually regulate blood glucose “automatically” like a pancreas would. Which makes treating diabetes with a GRI, not dissimilar to treating any other condition that requires a single dose of medication every day. You take the medicine and go about your business, not giving your condition a second thought in your day to day activities. That’s huge.

        This is all well and good, however, GRIs are little more than a lab experiment at the moment. Human trials are set up begin in 2025 sometime.

        So my point stands, make insulin cheap, let people live for a few more years until they can see the release of GRIs; where there is a real, tangible change in how they manage their condition.

        Everything else, is just variations on the same, bad, theme.

        My brother has used so many different brands and types of insulin, from long-acting to short, in vials, pen-like dispensers, and even a couple pumps… They’re all varying levels of bad. The least bad has been the pumps, but the pump isn’t dependent on what brand or type of insulin you use… It’s a tool to make it easier to manage the amount of insulin being recieved at any given time. Everything else is little more than a difference in labeling.

  • max55 ( max55@lemm.ee ) Banned
    link
    fedilink
    English
    arrow-up
    2
    ·
    2 years ago

    Guys, very seriously after the whole covid scam, do you still believe in this kind of stuff? The covid was biggest wealth-transfer to rich class in whole history.

    • Cowbee [he/they] ( Cowbee@lemmy.ml ) 
      link
      fedilink
      English
      arrow-up
      8
      ·
      2 years ago

      COVID is real. All crisis serves as a way to force the less wealthy of the Petite Bourgeoisie to sell off their Capital to the Haute Bourgeoisie, and in this manner furthers monopolization.